Researchers at City of Hope and TGen found that kidney cancer patients with more gene-splicing errors in their tumors are more likely to respond to treatment.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Study surveys dysfunctional gene splicing in metastatic kidney disease
101 Patients in study
13 Splicing Events Biomarkers identified
Metastatic Kidney Cancer Tumor type studied
High Burden = Better Response % Tumor cells flagged by splicing errors
13 splicing events linked to response